Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Otol Neurotol. 2017 Dec;38(10):e457–e459. doi: 10.1097/MAO.0000000000001567

TABLE 1.

Tabulation of the otherwise healthy vestibular schwannoma (VS) cases presenting with vertigo as the primary presenting symptom

Patient Number Age Sex Diagno Maximum Tumor sis Dimension (mm) Pretreatment Dizziness Duration Pretreatment Weekly Vertigo Frequency Pretreatment Vertigo Duration Medication Used for Resolution of Vertigo Time to Resolution After Initiating Treatment Eventual VS Treatment Follow-up Duration (Mo)
1 73 F VM 12 mm 7 years 7 0.25–2 hours Nortriptyline 50 mg 2 months Continued observation 9
2 74 F BPV 1.9 mm 3 years 7 < 1 minute Verapamil 120 mg 1 week CyberKnife radiation therapy 36
3 71 F VM 2.5 mm 3 years 5 1 hour Nortriptyline 75 mg 9 weeks Continued observation 11
4 47 F VM 10 mm 2 years 7 <1 minute Nortriptyline 75mg 9 months Continued observation 5
5 78 F VM 13 mm 3 years 2 0.5 hours Topiramate 25 mg 3 months Continued observation 14
6 62 M VM 14 mm 2 years 3 1–2 hours Nortriptyline 10 3 weeks CyberKnife radiation therapy 18
7 51 M BPV 20 mm 3 week 7 < 1 minute Epley maneuver 1 week Continued observation 24
8 41 F VM 10 mm 2.5 years 2 1 hour Verapamil 240 mg 3 months Continued observation 34
9 63 F VM 11 mm 1 year 4 2 hours Topiramate 150 mg 2 months Continued observation 22

BPV indicates benign positional vertigo; VM, vestibular migraine.